Study To Confirm NuQ® Test Accuracy In Lung Cancer Is Being Initiated
Lung Cancer, News
VolitionRx Limited announced that University Hospital Bonn in Germany is initiating a confirmatory study to evaluate the Nucleosomics® platform, VolitionRx’s novel technological platform for the diagnosis of lung cancer that utilizes an individualized blood ... Read more